tiprankstipranks
Precision BioSciences (DE:PBS0)
FRANKFURT:PBS0
Germany Market
PBS0
Precision BioSciences
RESEARCH TOOLSreports

Precision BioSciences (PBS0) Stock News & Sentiment

1 Followers
Precision BioSciences Begins First DMD Gene-Editing Trial
Premium
Company Announcements
Precision BioSciences Begins First DMD Gene-Editing Trial
9d ago
8K
DTIL
Precision BioSciences: Buy Rating Reiterated as ARCUS HBV and DMD Catalysts De-Risk Platform; $60 Price Target Maintained
Premium
Ratings
Precision BioSciences: Buy Rating Reiterated as ARCUS HBV and DMD Catalysts De-Risk Platform; $60 Price Target Maintained
21d ago
DTIL
Precision BioSciences Announces Key Executive Leadership Changes
Premium
Company Announcements
Precision BioSciences Announces Key Executive Leadership Changes
1M ago
8K
DTIL
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B
Premium
Company Announcements
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B
2M ago
8K
DTIL
Precision BioSciences Extends Term Loan Maturity to 2029
Premium
Company Announcements
Precision BioSciences Extends Term Loan Maturity to 2029
3M ago
8K
DTIL
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
Premium
Ratings
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
3M ago
DTIL
Precision BioSciences Reports Promising New Hepatitis B Trial Data
Premium
Company Announcements
Precision BioSciences Reports Promising New Hepatitis B Trial Data
3M ago
8K
DTIL
More DE:PBS0 News >

PBS0 News on the Web

Precision BioSciences: Buy Rating Reiterated as ARCUS HBV and DMD Catalysts De-Risk Platform; $60 Price Target Maintained
TipRanks News
Bullish
Precision BioSciences Advances Gene-Editing Programs in Hepatitis B
TipRanks News
Neutral
Precision BioSciences announces addition to the Russell 2000 Index
TipRanks News
Bullish
Precision BioSciences Extends Term Loan Maturity to 2029
TipRanks News
Neutral
H.C. Wainwright Reaffirms Their Buy Rating on Precision BioSciences (DTIL)
TipRanks News
Bullish
Analysts Conflicted on These Healthcare Names: MannKind (MNKD), Biohaven Ltd. (BHVN) and Precision BioSciences (DTIL)
TipRanks News
Bullish
Patrick Trucchio Reiterates Buy on Precision BioSciences with Unchanged $60 Price Target on Promising ELIMINATE-B Data and ARCUS-Based Upside
TipRanks News
Bullish
DTIL Advances Hepatitis B Cure Strategy: New Clinical Data Shows PBGENE-HBV Directly Eliminates Root Cause of Infection
Market Chameleon
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PBS0’s Media Buzz Sentiment?
Currently, no data Available
What is DE:PBS0’s weekly average amount of articles?
In an average week, 2.25 articles about DE:PBS0 are published.
    What is DE:PBS0’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    ATGGFActinogen Medical
    PTGXProtagonist Therapeutics
    WXIBFWuxi Biologics (Cayman)
    PMVPPMV Pharmaceuticals
    BBIOBridgeBio Pharma
    Showing the stocks with the most bullish news sentiment over the past week